Clinical Trial Update: Pharmacokinetic Study of Minocycline in Patients With Pulmonary Nontuberculous Mycobacterial Disease [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study of minocycline in patients with Mycobacterium avium complex pulmonary disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Avium Complex Pulmonary Disease

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Mycobacterium Avium Complex Pulmonary Disease | Phase 2 | Status: TERMINATED